- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 2, 2024 | 649.88M sh |
| Long Term Debt | Q2 2024 · Jun 30, 2024 | $119.69M |
| Long Term Debt | Q2 2024 · Dec 31, 2023 | $48.37M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $404.6M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $271.77M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $48.35M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $8.69M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $265.85M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $58.84M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $416.29M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $289.71M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $434.12M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $308.12M |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 634.47M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 628M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $0 |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$27.09M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $273.09M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $276.75M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $230.47M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.01 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.04 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.04 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $12.44M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $22.03M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$8.81M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$25.55M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$16.74M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$9.97M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$32.16M |